US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Soligenix, Inc.

0.4010

+0.02095.50%

Post-market: 0.42000.0190+4.74%19:47 EDT

Volume:989.16K

Turnover:408.16K

Market Cap:8.73M

PE:-0.31

High:0.4219

Open:0.3800

Low:0.3800

Close:0.3801

52wk High:3.44

52wk Low:0.2800

Shares:21.77M

Float Shares:20.77M

Volume Ratio:6.33

T/O Rate:4.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2743

EPS(LYR):-2.1354

ROE:-241.65%

ROA:-84.87%

PB:1.31

PE(LYR):-0.19

Loading ...

Overview Company News Filings

BRIEF-Soligenix Announces Recent Accomplishments And Year End 2025 Financial Results

Soligenix publishes corporate presentation; pipeline targets rare diseases with ~$2 billion in potential global annual sales

Soligenix (NASDAQ: SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behçet Disease

Soligenix’s SGX945 granted European Orphan Drug Designation in Behcet’s Disease

Soligenix shares rise; European Commission grants orphan drug designation for SGX945 in Behçet's disease

Soligenix Receives Orphan Drug Designation From the European Commission for Sgx945 for the Treatment of BehÇEt's Disease

THOMSON REUTERS

Soligenix (NASDAQ: SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach

Soligenix (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

Soligenix (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

Soligenix to present Phase 2 real-world HyBryte study results for early-stage CTCL at USCLC Workshop 2026

Hybryte™ Treatment Results to Be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

THOMSON REUTERS

Soligenix CEO Christopher Schaber Discusses Phase 3 HyBryte Interim Analysis Timeline in Podcast Interview

Soligenix announces HyBryte clinical summary published

Soligenix reports HyBryte clinical trial summary publication for early-stage CTCL in Expert Opinion on Investigational Drugs

Soligenix Inc expected to post a loss of 56 cents a share - Earnings Preview

Soligenix (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease

Soligenix SGX945 wins UK MHRA Promising Innovative Medicine designation for Behçet’s disease

Soligenix Announces Sgx945 Receives Promising Innovative Medicine Designation From the UK Medicines and Healthcare Products Regulatory Agency

THOMSON REUTERS

Soligenix (NASDAQ: SNGX) Leverages Platform Science for Broader Therapeutic Reach

Soligenix Receives Positive Opinion From the European Medicines Agency on the Request for Orphan Drug Designation for Sgx945 for the Treatment of BehÇEt's Disease

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SNGX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":0.401,"timestamp":1787342400000,"preClose":0.3801,"halted":0,"volume":989160,"hourTrading":{"tag":"盘后","latestPrice":0.42,"preClose":0.401,"latestTime":"19:47 EDT","volume":16642,"amount":6959.367322,"timestamp":1787356023670,"change":0.019,"changeRate":0.047382,"amplitude":0.060599},"delay":0,"changeRate":0.054985530123651746,"floatShares":20766115,"shares":21765500,"eps":-1.2743,"marketStatus":"Market Closed","change":0.0209,"latestTime":"08-21 16:00:00 EDT","open":0.380001,"high":0.4219,"low":0.380001,"amount":408161.7101772,"amplitude":0.110232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.2743,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.3801,"preHourTrading":{"tag":"盘前","latestPrice":0.38,"preClose":0.3801,"latestTime":"09:22 EDT","volume":1724,"amount":625.1023154,"timestamp":1787318527621,"change":-0.0001,"changeRate":-0.000263,"amplitude":0.113128},"postHourTrading":{"tag":"盘后","latestPrice":0.42,"preClose":0.401,"latestTime":"19:47 EDT","volume":16642,"amount":6959.367322,"timestamp":1787356023670,"change":0.019,"changeRate":0.047382,"amplitude":0.060599},"volumeRatio":6.332583893110883},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","floatShares":20766115,"roa":"-84.87%","roe":"-241.65%","lyrEps":-2.135442,"volumeRatio":6.332583893110883,"shares":21765500,"dividePrice":0,"high":0.4219,"amplitude":0.110232,"preClose":0.3801,"low":0.380001,"week52Low":0.28,"pbRate":"1.31","week52High":3.44,"institutionHeld":0.0165,"latestPrice":0.401,"eps":-1.2743,"divideRate":0,"volume":989160,"delay":0,"ttmEps":-1.2743,"open":0.380001,"prevYearClose":1.34,"prevWeekClose":0.4,"prevMonthClose":0.3739,"prevQuarterClose":0.396,"fiveDayClose":0.4,"twentyDayClose":0.3713,"sixtyDayClose":0.8657},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"SNGX","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2026-05-08","symbol":"SNGX","fiscalQuarterEnding":"2026/03","expectedEps":-0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.28},{"date":"2026-03-31","symbol":"SNGX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"Pre-MKt","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-07","symbol":"SNGX","fiscalQuarterEnding":"2025/09","expectedEps":-0.63,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-08-14","symbol":"SNGX","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1752724800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNGX","date":"2026-08-21","current":-0.314683,"percent":0.650122,"low":-4.013846,"twenty":-1.868768,"median":-1.061957,"eighty":-0.54572,"high":-0.26353,"avg":-1.246123,"sd":0.796702,"marketCap":8273058},"quantilePoints":[{"date":"2021-08-27","current":-3.529416,"twenty":-3.819297,"median":-3.140414,"eighty":-2.139444,"marketCap":40905829},{"date":"2021-09-03","current":-3.806233,"twenty":-3.819297,"median":-3.149818,"eighty":-2.140169,"marketCap":44114128},{"date":"2021-09-10","current":-4.013846,"twenty":-3.822057,"median":-3.152361,"eighty":-2.145333,"marketCap":46520354},{"date":"2021-09-17","current":-3.737029,"twenty":-3.822117,"median":-3.16435,"eighty":-2.145333,"marketCap":43312052},{"date":"2021-09-24","current":-3.546717,"twenty":-3.822117,"median":-3.180179,"eighty":-2.145333,"marketCap":41106347},{"date":"2021-10-01","current":-3.633222,"twenty":-3.822117,"median":-3.181533,"eighty":-2.145333,"marketCap":42108942},{"date":"2021-10-08","current":-3.59862,"twenty":-3.822117,"median":-3.189617,"eighty":-2.145333,"marketCap":41707904},{"date":"2021-10-15","current":-3.806233,"twenty":-3.822117,"median":-3.197852,"eighty":-2.150499,"marketCap":44114128},{"date":"2021-10-22","current":-3.494814,"twenty":-3.822117,"median":-3.211097,"eighty":-2.154035,"marketCap":40504791},{"date":"2021-10-29","current":-3.494814,"twenty":-3.822117,"median":-3.2141,"eighty":-2.161849,"marketCap":40504791},{"date":"2021-11-05","current":-3.42561,"twenty":-3.822117,"median":-3.220267,"eighty":-2.162699,"marketCap":39702715},{"date":"2021-11-12","current":-2.916544,"twenty":-3.822117,"median":-3.222002,"eighty":-2.170406,"marketCap":39044830},{"date":"2021-11-19","current":-2.741366,"twenty":-3.822117,"median":-3.218265,"eighty":-2.170406,"marketCap":36699653},{"date":"2021-11-26","current":-2.875872,"twenty":-3.822117,"median":-3.216049,"eighty":-2.170406,"marketCap":38500338},{"date":"2021-12-03","current":-2.562024,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":34298742},{"date":"2021-12-10","current":-2.446092,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":32746723},{"date":"2021-12-17","current":-2.394211,"twenty":-3.822117,"median":-3.211931,"eighty":-2.170406,"marketCap":32052174},{"date":"2021-12-23","current":-2.458582,"twenty":-3.822117,"median":-3.203637,"eighty":-2.170406,"marketCap":32913930},{"date":"2021-12-31","current":-2.114631,"twenty":-3.822117,"median":-3.191039,"eighty":-2.169084,"marketCap":28309324},{"date":"2022-01-07","current":-2.217909,"twenty":-3.822097,"median":-3.181959,"eighty":-2.166201,"marketCap":29691947},{"date":"2022-01-14","current":-2.069155,"twenty":-3.813481,"median":-3.181107,"eighty":-2.161849,"marketCap":27700521},{"date":"2022-01-21","current":-2.036489,"twenty":-3.810294,"median":-3.1662,"eighty":-2.161849,"marketCap":27263212},{"date":"2022-01-28","current":-1.97436,"twenty":-3.809605,"median":-3.158329,"eighty":-2.15359,"marketCap":26431467},{"date":"2022-02-04","current":-1.986209,"twenty":-3.809605,"median":-3.149818,"eighty":-2.148285,"marketCap":26590099},{"date":"2022-02-11","current":-2.014712,"twenty":-3.809605,"median":-3.144477,"eighty":-2.14007,"marketCap":26971673},{"date":"2022-02-18","current":-2.17772,"twenty":-3.809605,"median":-3.132783,"eighty":-2.139444,"marketCap":29153928},{"date":"2022-02-25","current":-2.306142,"twenty":-3.809605,"median":-3.129679,"eighty":-2.139444,"marketCap":30873154},{"date":"2022-03-04","current":-2.145054,"twenty":-3.809605,"median":-3.129679,"eighty":-2.138219,"marketCap":28716619},{"date":"2022-03-11","current":-2.312226,"twenty":-3.809605,"median":-3.124184,"eighty":-2.138219,"marketCap":30954613},{"date":"2022-03-18","current":-2.222556,"twenty":-3.806233,"median":-3.11997,"eighty":-2.138219,"marketCap":29754157},{"date":"2022-03-25","current":-2.309344,"twenty":-3.806233,"median":-3.105034,"eighty":-2.138219,"marketCap":30916027},{"date":"2022-04-01","current":-2.532554,"twenty":-3.806233,"median":-3.105034,"eighty":-2.139763,"marketCap":31786020},{"date":"2022-04-08","current":-2.529132,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":31743066},{"date":"2022-04-14","current":-2.481219,"twenty":-3.806233,"median":-3.105034,"eighty":-2.150636,"marketCap":31141708},{"date":"2022-04-22","current":-2.102362,"twenty":-3.806233,"median":-3.105034,"eighty":-2.152006,"marketCap":26386692},{"date":"2022-04-29","current":-1.80975,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":22714119},{"date":"2022-05-06","current":-1.772104,"twenty":-3.806233,"median":-3.105034,"eighty":-2.142794,"marketCap":22241624},{"date":"2022-05-13","current":-1.178605,"twenty":-3.806233,"median":-3.100739,"eighty":-2.140196,"marketCap":17133992},{"date":"2022-05-20","current":-1.543144,"twenty":-3.806233,"median":-3.091406,"eighty":-2.139444,"marketCap":22433476},{"date":"2022-05-27","current":-1.77383,"twenty":-3.806233,"median":-3.089475,"eighty":-2.129342,"marketCap":25787088},{"date":"2022-06-03","current":-1.514419,"twenty":-3.806233,"median":-3.087545,"eighty":-2.119815,"marketCap":22015888},{"date":"2022-06-10","current":-1.776792,"twenty":-3.806233,"median":-3.087545,"eighty":-2.115527,"marketCap":25830138},{"date":"2022-06-17","current":-1.687952,"twenty":-3.806233,"median":-3.087545,"eighty":-2.100887,"marketCap":24538630},{"date":"2022-06-24","current":-1.617473,"twenty":-3.806233,"median":-3.087545,"eighty":-2.092935,"marketCap":23514034},{"date":"2022-07-01","current":-1.719934,"twenty":-3.806233,"median":-3.087545,"eighty":-2.086976,"marketCap":25003573},{"date":"2022-07-08","current":-1.762281,"twenty":-3.806233,"median":-3.087545,"eighty":-2.078536,"marketCap":25619192},{"date":"2022-07-15","current":-2.025543,"twenty":-3.806233,"median":-3.087545,"eighty":-2.0727,"marketCap":29446357},{"date":"2022-07-22","current":-2.259783,"twenty":-3.806233,"median":-3.077014,"eighty":-2.0727,"marketCap":32851632},{"date":"2022-07-29","current":-2.592339,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":37686173},{"date":"2022-08-05","current":-2.679994,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":38960460},{"date":"2022-08-12","current":-2.539174,"twenty":-3.806233,"median":-3.068833,"eighty":-2.0727,"marketCap":38156702},{"date":"2022-08-19","current":-2.380834,"twenty":-3.793261,"median":-3.057725,"eighty":-2.0727,"marketCap":35777295},{"date":"2022-08-26","current":-2.280438,"twenty":-3.77381,"median":-3.037933,"eighty":-2.0727,"marketCap":34268616},{"date":"2022-09-02","current":-2.065302,"twenty":-3.75227,"median":-3.012696,"eighty":-2.072608,"marketCap":31035726},{"date":"2022-09-09","current":-1.986419,"twenty":-3.744873,"median":-2.99389,"eighty":-2.068643,"marketCap":29850333},{"date":"2022-09-16","current":-1.921878,"twenty":-3.736351,"median":-2.972351,"eighty":-2.06071,"marketCap":28880466},{"date":"2022-09-23","current":-1.455464,"twenty":-3.71974,"median":-2.963888,"eighty":-2.050413,"marketCap":21871566},{"date":"2022-09-30","current":-1.252663,"twenty":-3.703324,"median":-2.929273,"eighty":-2.049272,"marketCap":18824029},{"date":"2022-10-07","current":-1.641628,"twenty":-3.69525,"median":-2.907735,"eighty":-2.046565,"marketCap":24669091},{"date":"2022-10-14","current":-1.686663,"twenty":-3.686342,"median":-2.894033,"eighty":-2.042346,"marketCap":25345843},{"date":"2022-10-21","current":-1.804558,"twenty":-3.668494,"median":-2.865205,"eighty":-2.037717,"marketCap":27117466},{"date":"2022-10-28","current":-2.007933,"twenty":-3.667825,"median":-2.841668,"eighty":-2.029514,"marketCap":30173622},{"date":"2022-11-04","current":-1.893481,"twenty":-3.66653,"median":-2.8149,"eighty":-2.026959,"marketCap":28453728},{"date":"2022-11-11","current":-2.05165,"twenty":-3.663597,"median":-2.797124,"eighty":-2.021049,"marketCap":30259092},{"date":"2022-11-18","current":-1.905104,"twenty":-3.648917,"median":-2.778014,"eighty":-2.01711,"marketCap":28097730},{"date":"2022-11-25","current":-1.699939,"twenty":-3.641768,"median":-2.743928,"eighty":-2.014281,"marketCap":25071819},{"date":"2022-12-02","current":-1.64132,"twenty":-3.633222,"median":-2.735277,"eighty":-2.004814,"marketCap":24207273},{"date":"2022-12-09","current":-1.533755,"twenty":-3.633222,"median":-2.711283,"eighty":-1.996265,"marketCap":22620834},{"date":"2022-12-16","current":-1.846485,"twenty":-3.633222,"median":-2.682693,"eighty":-1.984215,"marketCap":27233184},{"date":"2022-12-23","current":-1.891329,"twenty":-3.633222,"median":-2.662821,"eighty":-1.97859,"marketCap":27894562},{"date":"2022-12-30","current":-1.32478,"twenty":-3.633222,"median":-2.64295,"eighty":-1.974296,"marketCap":19538728},{"date":"2023-01-06","current":-1.410357,"twenty":-3.630477,"median":-2.626074,"eighty":-1.970255,"marketCap":20800882},{"date":"2023-01-13","current":-1.377155,"twenty":-3.619207,"median":-2.596781,"eighty":-1.964148,"marketCap":20311194},{"date":"2023-01-20","current":-1.469416,"twenty":-3.619207,"median":-2.584653,"eighty":-1.961265,"marketCap":21671919},{"date":"2023-01-27","current":-1.409182,"twenty":-3.619207,"median":-2.562024,"eighty":-1.955717,"marketCap":20783547},{"date":"2023-02-03","current":-1.351886,"twenty":-3.615611,"median":-2.546439,"eighty":-1.950333,"marketCap":19938511},{"date":"2023-02-10","current":-1.047974,"twenty":-3.615611,"median":-2.539174,"eighty":-1.93629,"marketCap":15456214},{"date":"2023-02-17","current":-0.812914,"twenty":-3.615611,"median":-2.519549,"eighty":-1.920521,"marketCap":11989399},{"date":"2023-02-24","current":-0.744355,"twenty":-3.615611,"median":-2.50894,"eighty":-1.916691,"marketCap":10978245},{"date":"2023-03-03","current":-0.579814,"twenty":-3.615611,"median":-2.50315,"eighty":-1.905104,"marketCap":8551475},{"date":"2023-03-10","current":-0.628784,"twenty":-3.615611,"median":-2.498294,"eighty":-1.893481,"marketCap":9273728},{"date":"2023-03-17","current":-0.45249,"twenty":-3.615611,"median":-2.494874,"eighty":-1.873469,"marketCap":6673617},{"date":"2023-03-24","current":-0.360425,"twenty":-3.615611,"median":-2.490459,"eighty":-1.864593,"marketCap":5315782},{"date":"2023-03-31","current":-0.385889,"twenty":-3.614644,"median":-2.487664,"eighty":-1.852184,"marketCap":5691353},{"date":"2023-04-06","current":-0.368498,"twenty":-3.614644,"median":-2.487664,"eighty":-1.838884,"marketCap":5084661},{"date":"2023-04-14","current":-0.343373,"twenty":-3.615611,"median":-2.488267,"eighty":-1.81823,"marketCap":4737979},{"date":"2023-04-21","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.806924,"marketCap":4298921},{"date":"2023-04-28","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.796476,"marketCap":4298921},{"date":"2023-05-05","current":-0.486536,"twenty":-3.615611,"median":-2.488267,"eighty":-1.780665,"marketCap":6713384},{"date":"2023-05-12","current":-0.530952,"twenty":-3.615611,"median":-2.488267,"eighty":-1.774785,"marketCap":7326252},{"date":"2023-05-19","current":-0.450777,"twenty":-3.615611,"median":-2.488267,"eighty":-1.773356,"marketCap":4731101},{"date":"2023-05-26","current":-0.548639,"twenty":-3.615611,"median":-2.488267,"eighty":-1.762981,"marketCap":5758198},{"date":"2023-06-02","current":-0.556758,"twenty":-3.615611,"median":-2.488267,"eighty":-1.761231,"marketCap":5843414},{"date":"2023-06-09","current":-0.568435,"twenty":-3.615611,"median":-2.488267,"eighty":-1.758431,"marketCap":5965964},{"date":"2023-06-16","current":-0.553201,"twenty":-3.615611,"median":-2.488267,"eighty":-1.753075,"marketCap":5806081},{"date":"2023-06-23","current":-0.549104,"twenty":-3.616579,"median":-2.489363,"eighty":-1.755221,"marketCap":5763076},{"date":"2023-06-30","current":-0.549025,"twenty":-3.617546,"median":-2.490459,"eighty":-1.751843,"marketCap":5762256},{"date":"2023-07-07","current":-0.561243,"twenty":-3.617546,"median":-2.490459,"eighty":-1.719975,"marketCap":5890486},{"date":"2023-07-14","current":-0.534333,"twenty":-3.617546,"median":-2.490459,"eighty":-1.701031,"marketCap":5608055},{"date":"2023-07-21","current":-0.517398,"twenty":-3.617546,"median":-2.488267,"eighty":-1.696019,"marketCap":5430317},{"date":"2023-07-28","current":-0.487163,"twenty":-3.617546,"median":-2.48706,"eighty":-1.691433,"marketCap":5112988},{"date":"2023-08-04","current":-0.458552,"twenty":-3.617546,"median":-2.471478,"eighty":-1.68556,"marketCap":4812701},{"date":"2023-08-11","current":-0.492307,"twenty":-3.605533,"median":-2.464449,"eighty":-1.673383,"marketCap":5166973},{"date":"2023-08-18","current":-0.451047,"twenty":-3.604385,"median":-2.451581,"eighty":-1.658517,"marketCap":4733931},{"date":"2023-08-25","current":-0.474846,"twenty":-3.599792,"median":-2.429294,"eighty":-1.650503,"marketCap":4615829},{"date":"2023-09-01","current":-0.455119,"twenty":-3.59581,"median":-2.407007,"eighty":-1.641321,"marketCap":4424070},{"date":"2023-09-08","current":-0.515598,"twenty":-3.574766,"median":-2.401897,"eighty":-1.635487,"marketCap":5011970},{"date":"2023-09-15","current":-0.457243,"twenty":-3.566924,"median":-2.38362,"eighty":-1.627894,"marketCap":4444715},{"date":"2023-09-22","current":-0.50771,"twenty":-3.560315,"median":-2.374811,"eighty":-1.617598,"marketCap":4935296},{"date":"2023-09-29","current":-0.546143,"twenty":-3.551056,"median":-2.338167,"eighty":-1.605284,"marketCap":5308884},{"date":"2023-10-06","current":-0.576484,"twenty":-3.535509,"median":-2.330801,"eighty":-1.598066,"marketCap":5603822},{"date":"2023-10-13","current":-0.56637,"twenty":-3.529416,"median":-2.317858,"eighty":-1.582702,"marketCap":5505509},{"date":"2023-10-20","current":-0.529961,"twenty":-3.529416,"median":-2.309344,"eighty":-1.582674,"marketCap":5151583},{"date":"2023-10-27","current":-0.515296,"twenty":-3.529416,"median":-2.303676,"eighty":-1.573299,"marketCap":5009030},{"date":"2023-11-03","current":-0.488595,"twenty":-3.529416,"median":-2.295319,"eighty":-1.555321,"marketCap":4749485},{"date":"2023-11-10","current":-0.420732,"twenty":-3.529416,"median":-2.279706,"eighty":-1.52544,"marketCap":4089807},{"date":"2023-11-17","current":-0.49227,"twenty":-3.529416,"median":-2.266533,"eighty":-1.497359,"marketCap":3974781},{"date":"2023-11-24","current":-0.519915,"twenty":-3.529416,"median":-2.255719,"eighty":-1.484111,"marketCap":4197997},{"date":"2023-12-01","current":-1.259878,"twenty":-3.529416,"median":-2.246954,"eighty":-1.471408,"marketCap":10172748},{"date":"2023-12-08","current":-0.944716,"twenty":-3.529416,"median":-2.243626,"eighty":-1.458806,"marketCap":7628004},{"date":"2023-12-15","current":-0.760271,"twenty":-3.529416,"median":-2.242091,"eighty":-1.44978,"marketCap":6138727},{"date":"2023-12-22","current":-0.781479,"twenty":-3.529416,"median":-2.242091,"eighty":-1.42203,"marketCap":6309968},{"date":"2023-12-29","current":-0.878907,"twenty":-3.529416,"median":-2.242858,"eighty":-1.409887,"marketCap":7096639},{"date":"2024-01-05","current":-1.166178,"twenty":-3.529416,"median":-2.243626,"eighty":-1.402478,"marketCap":9416175},{"date":"2024-01-12","current":-1.113479,"twenty":-3.529416,"median":-2.241771,"eighty":-1.377273,"marketCap":8990667},{"date":"2024-01-19","current":-0.798188,"twenty":-3.529416,"median":-2.240902,"eighty":-1.367144,"marketCap":6444885},{"date":"2024-01-26","current":-0.76477,"twenty":-3.529416,"median":-2.232464,"eighty":-1.350711,"marketCap":6175051},{"date":"2024-02-02","current":-0.861041,"twenty":-3.529416,"median":-2.232464,"eighty":-1.323591,"marketCap":6952381},{"date":"2024-02-09","current":-0.832892,"twenty":-3.529416,"median":-2.232464,"eighty":-1.284479,"marketCap":6725098},{"date":"2024-02-16","current":-0.935719,"twenty":-3.529416,"median":-2.232464,"eighty":-1.19338,"marketCap":7555357},{"date":"2024-02-23","current":-0.96014,"twenty":-3.529416,"median":-2.232464,"eighty":-1.170061,"marketCap":7752543},{"date":"2024-03-01","current":-0.937004,"twenty":-3.529416,"median":-2.232314,"eighty":-1.094071,"marketCap":7565735},{"date":"2024-03-08","current":-1.015409,"twenty":-3.529416,"median":-2.232314,"eighty":-1.04266,"marketCap":8198808},{"date":"2024-03-15","current":-0.818497,"twenty":-3.529416,"median":-2.232314,"eighty":-0.985743,"marketCap":6608861},{"date":"2024-03-22","current":-1.096879,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6735639},{"date":"2024-03-28","current":-1.040493,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6389385},{"date":"2024-04-05","current":-0.805692,"twenty":-3.529416,"median":-2.232163,"eighty":-0.951971,"marketCap":4947537},{"date":"2024-04-12","current":-0.666183,"twenty":-3.529416,"median":-2.232163,"eighty":-0.937467,"marketCap":4090848},{"date":"2024-04-19","current":-0.746049,"twenty":-3.529416,"median":-2.232163,"eighty":-0.925458,"marketCap":4581287},{"date":"2024-04-26","current":-0.990316,"twenty":-3.529416,"median":-2.231918,"eighty":-0.92158,"marketCap":6081264},{"date":"2024-05-03","current":-0.938133,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5760823},{"date":"2024-05-10","current":-0.941612,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5782185},{"date":"2024-05-17","current":-0.792348,"twenty":-3.529416,"median":-2.231918,"eighty":-0.90316,"marketCap":5554316},{"date":"2024-05-24","current":-0.729366,"twenty":-3.529416,"median":-2.231918,"eighty":-0.885025,"marketCap":5112819},{"date":"2024-05-31","current":-0.711081,"twenty":-3.529416,"median":-2.231918,"eighty":-0.868111,"marketCap":4984642},{"date":"2024-06-07","current":-0.584609,"twenty":-3.529416,"median":-2.231918,"eighty":-0.841478,"marketCap":4098079},{"date":"2024-06-14","current":-0.584609,"twenty":-3.529416,"median":-2.232163,"eighty":-0.825714,"marketCap":4098079},{"date":"2024-06-21","current":-0.5184,"twenty":-3.529416,"median":-2.232314,"eighty":-0.813414,"marketCap":3633959},{"date":"2024-06-28","current":-0.373304,"twenty":-3.529416,"median":-2.233626,"eighty":-0.808757,"marketCap":2616845},{"date":"2024-07-05","current":-0.318365,"twenty":-3.529416,"median":-2.233626,"eighty":-0.804561,"marketCap":2231725},{"date":"2024-07-12","current":-1.077653,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7554290},{"date":"2024-07-15","current":-1.046662,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7337043},{"date":"2024-08-02","current":-0.618418,"twenty":-3.535509,"median":-2.215749,"eighty":-0.797123,"marketCap":4335076},{"date":"2024-08-09","current":-0.442331,"twenty":-3.535509,"median":-2.205592,"eighty":-0.792348,"marketCap":3100715},{"date":"2024-08-16","current":-1.081532,"twenty":-3.535509,"median":-2.189844,"eighty":-0.792348,"marketCap":7616606},{"date":"2024-08-23","current":-1.372962,"twenty":-3.535509,"median":-2.17772,"eighty":-0.792348,"marketCap":9668985},{"date":"2024-08-30","current":-1.058865,"twenty":-3.535509,"median":-2.174327,"eighty":-0.792348,"marketCap":7456976},{"date":"2024-09-06","current":-1.343819,"twenty":-3.535509,"median":-2.166303,"eighty":-0.792348,"marketCap":9463747},{"date":"2024-09-13","current":-1.110675,"twenty":-3.535509,"median":-2.161246,"eighty":-0.792348,"marketCap":7821844},{"date":"2024-09-20","current":-1.240199,"twenty":-3.535509,"median":-2.156951,"eighty":-0.792348,"marketCap":8734012},{"date":"2024-09-27","current":-1.246676,"twenty":-3.535509,"median":-2.145374,"eighty":-0.792348,"marketCap":8779620},{"date":"2024-10-04","current":-1.279057,"twenty":-3.535509,"median":-2.13956,"eighty":-0.792348,"marketCap":9007662},{"date":"2024-10-11","current":-1.292009,"twenty":-3.535509,"median":-2.13101,"eighty":-0.792348,"marketCap":9098879},{"date":"2024-10-18","current":-1.175437,"twenty":-3.535509,"median":-2.12822,"eighty":-0.792348,"marketCap":8277928},{"date":"2024-10-25","current":-1.20458,"twenty":-3.535509,"median":-2.123577,"eighty":-0.792348,"marketCap":8483166},{"date":"2024-10-31","current":-1.207818,"twenty":-3.535509,"median":-2.107658,"eighty":-0.792348,"marketCap":8505970},{"date":"2024-11-08","current":-1.123627,"twenty":-3.535509,"median":-2.074279,"eighty":-0.792348,"marketCap":7913060},{"date":"2024-11-15","current":-1.300862,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":9234956},{"date":"2024-11-22","current":-1.187744,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":8431916},{"date":"2024-11-29","current":-1.184209,"twenty":-3.535509,"median":-2.049939,"eighty":-0.792348,"marketCap":8406821},{"date":"2024-12-06","current":-1.131184,"twenty":-3.535509,"median":-2.033927,"eighty":-0.792348,"marketCap":8030396},{"date":"2024-12-13","current":-1.170069,"twenty":-3.535509,"median":-2.017112,"eighty":-0.792348,"marketCap":8306441},{"date":"2024-12-20","current":-1.088765,"twenty":-3.535509,"median":-2.001581,"eighty":-0.792348,"marketCap":7729256},{"date":"2024-12-27","current":-1.021601,"twenty":-3.535509,"median":-1.986209,"eighty":-0.792348,"marketCap":7252452},{"date":"2025-01-03","current":-1.039276,"twenty":-3.535509,"median":-1.976601,"eighty":-0.792348,"marketCap":7377927},{"date":"2025-01-10","current":-1.155929,"twenty":-3.529416,"median":-1.97197,"eighty":-0.792348,"marketCap":8206061},{"date":"2025-01-17","current":-0.802434,"twenty":-3.523734,"median":-1.964077,"eighty":-0.792348,"marketCap":5696562},{"date":"2025-01-24","current":-0.887273,"twenty":-3.508918,"median":-1.953718,"eighty":-0.792348,"marketCap":6298842},{"date":"2025-01-31","current":-0.816574,"twenty":-3.487384,"median":-1.94499,"eighty":-0.792348,"marketCap":5796942},{"date":"2025-02-07","current":-0.830713,"twenty":-3.464081,"median":-1.928314,"eighty":-0.792348,"marketCap":5897322},{"date":"2025-02-14","current":-0.869598,"twenty":-3.460004,"median":-1.914564,"eighty":-0.792348,"marketCap":6173367},{"date":"2025-02-21","current":-0.862528,"twenty":-3.449367,"median":-1.905104,"eighty":-0.792348,"marketCap":6123177},{"date":"2025-02-28","current":-0.795364,"twenty":-3.435067,"median":-1.886817,"eighty":-0.792348,"marketCap":5646372},{"date":"2025-03-07","current":-0.823644,"twenty":-3.423562,"median":-1.846485,"eighty":-0.790373,"marketCap":5847132},{"date":"2025-03-14","current":-0.813039,"twenty":-3.41639,"median":-1.80975,"eighty":-0.790373,"marketCap":5771847},{"date":"2025-03-21","current":-0.841318,"twenty":-3.407348,"median":-1.782714,"eighty":-0.790373,"marketCap":5972607},{"date":"2025-03-28","current":-0.866528,"twenty":-3.405471,"median":-1.77383,"eighty":-0.790373,"marketCap":7163218},{"date":"2025-04-04","current":-0.794114,"twenty":-3.378355,"median":-1.754307,"eighty":-0.790373,"marketCap":6564600},{"date":"2025-04-11","current":-0.72147,"twenty":-3.370724,"median":-1.718749,"eighty":-0.782944,"marketCap":5964089},{"date":"2025-04-17","current":-0.786365,"twenty":-3.368231,"median":-1.700232,"eighty":-0.779049,"marketCap":6500542},{"date":"2025-04-25","current":-0.822629,"twenty":-3.349519,"median":-1.687952,"eighty":-0.778595,"marketCap":6800324},{"date":"2025-05-02","current":-0.732922,"twenty":-3.335701,"median":-1.677345,"eighty":-0.767341,"marketCap":6058757},{"date":"2025-05-09","current":-0.752009,"twenty":-3.318337,"median":-1.658339,"eighty":-0.75921,"marketCap":6216537},{"date":"2025-05-16","current":-0.625327,"twenty":-3.306695,"median":-1.64132,"eighty":-0.752009,"marketCap":5995645},{"date":"2025-05-23","current":-0.623044,"twenty":-3.300954,"median":-1.631589,"eighty":-0.744363,"marketCap":5973753},{"date":"2025-05-30","current":-0.653685,"twenty":-3.291097,"median":-1.613804,"eighty":-0.737916,"marketCap":6267544},{"date":"2025-06-06","current":-0.626449,"twenty":-3.282404,"median":-1.587127,"eighty":-0.732937,"marketCap":6006396},{"date":"2025-06-13","current":-0.626449,"twenty":-3.276897,"median":-1.572151,"eighty":-0.718851,"marketCap":6006396},{"date":"2025-06-20","current":-0.607723,"twenty":-3.27413,"median":-1.559154,"eighty":-0.711081,"marketCap":5826857},{"date":"2025-06-27","current":-0.466432,"twenty":-3.268842,"median":-1.519397,"eighty":-0.698758,"marketCap":4472154},{"date":"2025-07-03","current":-0.408553,"twenty":-3.257603,"median":-1.473383,"eighty":-0.664356,"marketCap":3917215},{"date":"2025-07-11","current":-0.432386,"twenty":-3.236874,"median":-1.452959,"eighty":-0.65419,"marketCap":4145719},{"date":"2025-07-18","current":-0.463027,"twenty":-3.217218,"median":-1.430621,"eighty":-0.643472,"marketCap":4439510},{"date":"2025-07-25","current":-0.473241,"twenty":-3.2141,"median":-1.408221,"eighty":-0.637343,"marketCap":4537440},{"date":"2025-08-01","current":-0.997551,"twenty":-3.188721,"median":-1.381754,"eighty":-0.627362,"marketCap":9564533},{"date":"2025-08-08","current":-1.120117,"twenty":-3.181107,"median":-1.370141,"eighty":-0.627362,"marketCap":10739698},{"date":"2025-08-15","current":-1.000956,"twenty":-3.164793,"median":-1.351886,"eighty":-0.627362,"marketCap":9597177},{"date":"2025-08-22","current":-1.389916,"twenty":-3.149818,"median":-1.351739,"eighty":-0.627362,"marketCap":14399515},{"date":"2025-08-29","current":-1.265816,"twenty":-3.133169,"median":-1.335619,"eighty":-0.627362,"marketCap":13113844},{"date":"2025-09-05","current":-1.257543,"twenty":-3.117677,"median":-1.322798,"eighty":-0.627006,"marketCap":13028132},{"date":"2025-09-12","current":-1.14999,"twenty":-3.103112,"median":-1.30595,"eighty":-0.627362,"marketCap":11913884},{"date":"2025-09-19","current":-1.141717,"twenty":-3.087143,"median":-1.297273,"eighty":-0.627362,"marketCap":11828173},{"date":"2025-09-26","current":-0.670138,"twenty":-3.067674,"median":-1.286016,"eighty":-0.627362,"marketCap":6942623},{"date":"2025-10-03","current":-0.529492,"twenty":-3.01938,"median":-1.275424,"eighty":-0.623501,"marketCap":5485529},{"date":"2025-10-10","current":-1.442653,"twenty":-2.995922,"median":-1.267432,"eighty":-0.616672,"marketCap":14945873},{"date":"2025-10-17","current":-1.249225,"twenty":-2.91443,"median":-1.264341,"eighty":-0.616672,"marketCap":12941957},{"date":"2025-10-24","current":-1.289522,"twenty":-2.875231,"median":-1.264341,"eighty":-0.616672,"marketCap":13359440},{"date":"2025-10-31","current":-1.216987,"twenty":-2.813038,"median":-1.258586,"eighty":-0.616672,"marketCap":12607971},{"date":"2025-11-07","current":-1.031618,"twenty":-2.781244,"median":-1.253152,"eighty":-0.616672,"marketCap":10687552},{"date":"2025-11-14","current":-1.245919,"twenty":-2.740725,"median":-1.250644,"eighty":-0.616672,"marketCap":13918859},{"date":"2025-11-21","current":-1.146607,"twenty":-2.677684,"median":-1.246297,"eighty":-0.616672,"marketCap":12809385},{"date":"2025-11-28","current":-1.435516,"twenty":-2.656351,"median":-1.246297,"eighty":-0.616672,"marketCap":16036946},{"date":"2025-12-05","current":-1.471629,"twenty":-2.625475,"median":-1.246297,"eighty":-0.616672,"marketCap":16440391},{"date":"2025-12-12","current":-1.471629,"twenty":-2.589141,"median":-1.246297,"eighty":-0.616672,"marketCap":16440391},{"date":"2025-12-19","current":-1.110493,"twenty":-2.546865,"median":-1.242649,"eighty":-0.616672,"marketCap":12405939},{"date":"2025-12-26","current":-1.30009,"twenty":-2.53187,"median":-1.240895,"eighty":-0.616672,"marketCap":14524027},{"date":"2026-01-02","current":-1.209806,"twenty":-2.515486,"median":-1.23858,"eighty":-0.616672,"marketCap":13515414},{"date":"2026-01-09","current":-1.30009,"twenty":-2.498557,"median":-1.23858,"eighty":-0.616672,"marketCap":14524027},{"date":"2026-01-16","current":-1.209806,"twenty":-2.489022,"median":-1.236891,"eighty":-0.616672,"marketCap":13515414},{"date":"2026-01-23","current":-1.282033,"twenty":-2.465907,"median":-1.236891,"eighty":-0.616672,"marketCap":14322304},{"date":"2026-01-30","current":-1.182721,"twenty":-2.437573,"median":-1.23371,"eighty":-0.616672,"marketCap":13212830},{"date":"2026-02-06","current":-0.938954,"twenty":-2.392653,"median":-1.223977,"eighty":-0.616672,"marketCap":10489575},{"date":"2026-02-13","current":-0.95701,"twenty":-2.376157,"median":-1.215641,"eighty":-0.616672,"marketCap":10691297},{"date":"2026-02-20","current":-1.002153,"twenty":-2.339841,"median":-1.209806,"eighty":-0.616672,"marketCap":11195604},{"date":"2026-02-27","current":-1.038266,"twenty":-2.333363,"median":-1.202678,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-03-06","current":-1.038266,"twenty":-2.311663,"median":-1.186246,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-03-13","current":-1.101465,"twenty":-2.300249,"median":-1.182902,"eighty":-0.616672,"marketCap":12305078},{"date":"2026-03-20","current":-1.101465,"twenty":-2.274431,"median":-1.177245,"eighty":-0.616672,"marketCap":12305078},{"date":"2026-03-27","current":-1.092437,"twenty":-2.242027,"median":-1.172338,"eighty":-0.616672,"marketCap":12204217},{"date":"2026-04-02","current":-1.04681,"twenty":-2.22985,"median":-1.169515,"eighty":-0.616672,"marketCap":11599049},{"date":"2026-04-10","current":-1.060336,"twenty":-2.208657,"median":-1.163574,"eighty":-0.616672,"marketCap":11748930},{"date":"2026-04-17","current":-1.08824,"twenty":-2.18478,"median":-1.155028,"eighty":-0.616672,"marketCap":12058112},{"date":"2026-04-24","current":-1.274264,"twenty":-2.169144,"median":-1.155028,"eighty":-0.616672,"marketCap":14119328},{"date":"2026-05-01","current":-0.320891,"twenty":-2.129097,"median":-1.14999,"eighty":-0.61283,"marketCap":3555597},{"date":"2026-05-08","current":-0.286663,"twenty":-2.081507,"median":-1.142422,"eighty":-0.594278,"marketCap":3176333},{"date":"2026-05-15","current":-0.381794,"twenty":-2.073297,"median":-1.137579,"eighty":-0.581773,"marketCap":4182206},{"date":"2026-05-22","current":-0.366929,"twenty":-2.051754,"median":-1.132262,"eighty":-0.575674,"marketCap":4019370},{"date":"2026-05-29","current":-0.915065,"twenty":-2.036904,"median":-1.123627,"eighty":-0.572224,"marketCap":10023692},{"date":"2026-06-05","current":-0.452452,"twenty":-2.024594,"median":-1.115479,"eighty":-0.571959,"marketCap":4956193},{"date":"2026-06-12","current":-0.405504,"twenty":-2.006663,"median":-1.111444,"eighty":-0.56859,"marketCap":4441920},{"date":"2026-06-18","current":-0.544027,"twenty":-1.991375,"median":-1.110493,"eighty":-0.568393,"marketCap":5959317},{"date":"2026-06-26","current":-0.534554,"twenty":-1.976601,"median":-1.108623,"eighty":-0.564568,"marketCap":5855548},{"date":"2026-07-02","current":-0.537261,"twenty":-1.972438,"median":-1.101465,"eighty":-0.561761,"marketCap":5885197},{"date":"2026-07-10","current":-0.49788,"twenty":-1.963722,"median":-1.095099,"eighty":-0.559253,"marketCap":5453813},{"date":"2026-07-17","current":-0.486783,"twenty":-1.950563,"median":-1.088922,"eighty":-0.556681,"marketCap":5332255},{"date":"2026-07-24","current":-0.498692,"twenty":-1.939664,"median":-1.083408,"eighty":-0.552691,"marketCap":5462708},{"date":"2026-07-31","current":-0.507488,"twenty":-1.922968,"median":-1.077924,"eighty":-0.549025,"marketCap":5559065},{"date":"2026-08-07","current":-0.512631,"twenty":-1.908397,"median":-1.069638,"eighty":-0.54572,"marketCap":5615397},{"date":"2026-08-14","current":-0.809659,"twenty":-1.894915,"median":-1.065351,"eighty":-0.54572,"marketCap":8290470},{"date":"2026-08-21","current":-0.807959,"twenty":-1.868768,"median":-1.061957,"eighty":-0.54572,"marketCap":8273058}],"updateTime":1787499789605},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNGX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623858503","title":"BRIEF-Soligenix Announces Recent Accomplishments And Year End 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2623858503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623858503?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:40","pubTimestamp":1774957200,"startTime":"0","endTime":"0","summary":"BRIEF-Soligenix Announces Recent Accomplishments And Year End 2025 Financial ResultsSoligenix Inc SNGX.O:SOLIGENIX ANNOUNCES RECENT ACCOMPLISHMENTS AND YEAR END 2025 FINANCIAL RESULTSSource text: ID:nPn3t9xShaFurther company coverage: SNGX.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUAB5MW3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896358","title":"Soligenix publishes corporate presentation; pipeline targets rare diseases with ~$2 billion in potential global annual sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896358","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896358?lang=en_us&edition=fundamental","pubTime":"2026-03-27 03:57","pubTimestamp":1774555060,"startTime":"0","endTime":"0","summary":"Soligenix said it is focused on developing and commercializing treatments for rare diseases, with operations organized into Specialized BioTherapeutics and Public Health Solutions segments.For HyBryte in cutaneous T-cell lymphoma, the company cited a statistically significant Phase 3 primary endpoint with p=0.04 and reported a 49% response rate after 18 weeks of treatment in the FLASH study.Soligenix said the confirmatory Phase 3 FLASH2 study began enrollment in January 2025 and had enrolled 66 of about 80 patients as of Feb. 10, 2026.For SGX302 in mild-to-moderate psoriasis, the company said a Phase 2a study was completed with clinical success observed using both ointment and gel formulations.Soligenix said it has received NIH contract awards of USD 30 million to date supporting its ricin vaccine program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDLbLXfWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622862597","title":"Soligenix (NASDAQ: SNGX) Receives EU Orphan Drug Designation For Dusquetide In Behçet Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2622862597","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622862597?lang=en_us&edition=fundamental","pubTime":"2026-03-27 00:00","pubTimestamp":1774540823,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 26th, 2026, FinanceWire Soligenix (NASDAQ:SNGX) announced the European Commission has granted orphan ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-receives-eu-orphan-drug-designation-for-dusquetide-in-behcet-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-receives-eu-orphan-drug-designation-for-dusquetide-in-behcet-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","BK4139","SQQQ","TQQQ","NQmain","QDTE","NVIW.SI","QYLG","JEPQ",".IXIC","QLD","GPIQ","QQQY","QQQE","BK4156","FTEC","QID","IYW","SNGX","QQQJ","MNQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622854244","title":"Soligenix’s SGX945 granted European Orphan Drug Designation in Behcet’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854244","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854244?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:36","pubTimestamp":1774524984,"startTime":"0","endTime":"0","summary":"Soligenix (SNGX) announced that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soligenixs-sgx945-granted-european-orphan-drug-designation-in-behcets-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soligenixs-sgx945-granted-european-orphan-drug-designation-in-behcets-disease-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622854268","title":"Soligenix shares rise; European Commission grants orphan drug designation for SGX945 in Behçet's disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854268?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:31","pubTimestamp":1774524676,"startTime":"0","endTime":"0","summary":"European Commission granted orphan drug designation to Soligenix’s dusquetide  for the treatment of Behet's disease, following a positive recommendation from the EMA’s Committee for Orphan Medicinal Products.The designation provides 10-year marketing exclusivity in the EU after approval and access to the centralized authorization procedure.SGX945 previously received orphan drug and fast track designations from the FDA for Behet's disease.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3WCnSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622854579","title":"Soligenix Receives Orphan Drug Designation From the European Commission for Sgx945 for the Treatment of BehÇEt's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854579","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854579?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:30","pubTimestamp":1774524600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nTUAX7W9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622005501","title":"Soligenix (NASDAQ: SNGX) Spotlighted in Recent Zacks Research Report as Key Clinical Milestones Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005501","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005501?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:00","pubTimestamp":1774458032,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 25th, 2026, FinanceWire Soligenix is entering a pivotal period marked by several anticipated clinical readouts ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-spotlighted-in-recent-zacks-research-report-as-key-clinical-milestones-approach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-spotlighted-in-recent-zacks-research-report-as-key-clinical-milestones-approach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JEPQ","QQQE","QDTE","QQQY","NQmain","SQQQ","GPIQ","NVIW.SI","PSQ","MNQmain","IYW",".IXIC","QID","SNGX","QYLG","QLD","BK4139","TQQQ","FTEC","QQQJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622309143","title":"Soligenix (NASDAQ: SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622309143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622309143?lang=en_us&edition=fundamental","pubTime":"2026-03-25 00:30","pubTimestamp":1774369817,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 24th, 2026, FinanceWire Soligenix (NASDAQ:SNGX) announced that new supportive trial data for HyB...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-hybryte-data-to-be-presented-at-usclc-workshop-ahead-of-aad-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-hybryte-data-to-be-presented-at-usclc-workshop-ahead-of-aad-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","NVIW.SI",".IXIC","SQQQ","USJW.SI","PSQ","JEPQ","TSYW.SI","MNQmain","USAW.SI","QYLG","BK4139","QQQE","GPIQ","QID","QQQY","TQQQ","NQmain","QLD","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621700416","title":"Soligenix (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2621700416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621700416?lang=en_us&edition=fundamental","pubTime":"2026-03-24 00:00","pubTimestamp":1774281617,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 23rd, 2026, FinanceWire Designations granted by leading global regulatory agencies play a critical role in adva...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-strengthens-rare-disease-pipeline-program-through-uk-regulatory-innovation-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-strengthens-rare-disease-pipeline-program-through-uk-regulatory-innovation-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNGX","SQQQ","NQmain","QYLG","USAW.SI","TQQQ","GPIQ","QQQY","JEPQ","QQQE","QQQJ","MNQmain","PSQ","NVIW.SI","USJW.SI",".IXIC","BK4139","TSYW.SI","QLD","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621214770","title":"Soligenix to present Phase 2 real-world HyBryte study results for early-stage CTCL at USCLC Workshop 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621214770","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621214770?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:30","pubTimestamp":1774265445,"startTime":"0","endTime":"0","summary":"Soligenix said results from supportive studies of HyBryte  for early-stage cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop ahead of the American Academy of Dermatology Annual Meeting.Ellen Kim will give an oral presentation on a Phase 2 investigator-initiated real-world study  evaluating topical hypericin ointment photodynamic therapy for early-stage mycosis fungoides/CTCL.A poster will report results from a pilot study comparing HyBryte versus Valchlor  in CTCL, with Brian Poligone listed as principal investigator for the comparability study.Soligenix also described the ongoing confirmatory Phase 3 FLASH2 trial as a randomized, double-blind, placebo-controlled multicenter study planned to enroll about 80 subjects, with a blinded interim analysis expected in 2Q2026.The company noted an FDA Orphan Products Development grant of USD 2.6 million over 4 years awarded to the University of Pennsylvania to support an investigator-initiate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL5RwnZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770274","title":"Hybryte™ Treatment Results to Be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770274?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:30","pubTimestamp":1774265400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nTUA96MLM2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620924771","title":"Soligenix CEO Christopher Schaber Discusses Phase 3 HyBryte Interim Analysis Timeline in Podcast Interview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924771","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620924771?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:03","pubTimestamp":1773921809,"startTime":"0","endTime":"0","summary":"Christopher Schaber, chairman, president and CEO of Soligenix, discussed an upcoming interim analysis by the Data Monitoring Committee for the Phase 3 FLASH2 study of HyBryte for cutaneous T-cell lymphoma.He said the interim review will assess safety and evaluate efficacy against the primary endpoint, with possible outcomes including continuing enrollment to 80 patients, stopping early, or re-estimating sample size.Schaber cited a blinded aggregate response rate of 48% at 50 patients and compared it with a 25% aggregate rate implied by the study’s assumed 40% response for HyBryte and 10% for placebo.He said top-line results are anticipated in the second half of the year and described the interim analysis and later data as key milestones for potential commercialization or partnership discussions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL3rS4SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","BK4112","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424642","title":"Soligenix announces HyBryte clinical summary published","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424642","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424642?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:36","pubTimestamp":1773920203,"startTime":"0","endTime":"0","summary":"Soligenix (SNGX) announced today that a summary of all the clinical trials completed to date evaluating HyBryte as a treatment for cutaneous T-cell...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soligenix-announces-hybryte-clinical-summary-published-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soligenix-announces-hybryte-clinical-summary-published-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620242512","title":"Soligenix reports HyBryte clinical trial summary publication for early-stage CTCL in Expert Opinion on Investigational Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620242512?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:31","pubTimestamp":1773919862,"startTime":"0","endTime":"0","summary":"Soligenix reported that a clinical summary of trials evaluating HyBryte  for early-stage cutaneous T-cell lymphoma was published in Expert Opinion on Investigational Drugs, authored by Brian Poligone.In the Phase 3 FLASH trial , 16% of patients receiving HyBryte achieved at least a 50% reduction in lesions at 8 weeks versus 4% with placebo.During Cycle 2 of FLASH, a 40% response rate was reported among patients receiving 12 weeks of HyBryte.Soligenix said the confirmatory Phase 3 FLASH2 study is ongoing, with a blinded interim analysis expected in 2Q 2026.The company also noted an FDA Orphan Products Development grant of USD 2.6 million awarded to the University of Pennsylvania to support an investigator-initiated study of HyBryte, including home-use evaluation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL6cF3jH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620289422","title":"Soligenix Inc  expected to post a loss of 56 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620289422","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620289422?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:46","pubTimestamp":1773751566,"startTime":"0","endTime":"0","summary":"Soligenix Inc  expected to post a loss of56cents a share - Earnings Preview Soligenix Inc SNGX.OQ SNGX.O is expected to  show no change in quarterly revenue when it reports  results on March 19 (estim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL8N40515L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618952613","title":"Soligenix (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2618952613","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618952613?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:00","pubTimestamp":1773158424,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 10th, 2026, FinanceWire Soligenix (NASDAQ:SNGX) announced that SGX945 (dusquetide) has received Promising ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-sgx945-granted-promising-innovative-medicine-designation-in-uk-for-behcet-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-sgx945-granted-promising-innovative-medicine-designation-in-uk-for-behcet-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","GPIQ","USAW.SI","QQQJ","TQQQ","SQQQ","QYLG","MNQmain","BK4139","QQQE","QQQY","NQmain",".IXIC","JEPQ","NVIW.SI","SNGX","QLD","USJW.SI","TSYW.SI","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618937159","title":"Soligenix SGX945 wins UK MHRA Promising Innovative Medicine designation for Behçet’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937159","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937159?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:54","pubTimestamp":1773143656,"startTime":"0","endTime":"0","summary":"Soligenix said the UK Medicines and Healthcare Products Regulatory Agency granted SGX945  a Promising Innovative Medicine designation for treating Behet's disease. The designation is a prerequisite for potential inclusion in the UK Early Access to Medicines Scheme . Soligenix cited Phase 2 clinical data showing a 40% improvement versus placebo on an oral-ulcer endpoint compared with apremilast’s 37% improvement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Soligenix Inc. published the original content used to generate this news brief on March 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL7H1Kzc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618932475","title":"Soligenix Announces Sgx945 Receives Promising Innovative Medicine Designation From the UK Medicines and Healthcare Products Regulatory Agency","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618932475?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:31","pubTimestamp":1773142313,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617502354","title":"Soligenix (NASDAQ: SNGX) Leverages Platform Science for Broader Therapeutic Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2617502354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617502354?lang=en_us&edition=fundamental","pubTime":"2026-03-06 14:00","pubTimestamp":1772776808,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, March 6th, 2026, FinanceWire Platform-based drug development has gained traction across the biotechnology industry be...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-leverages-platform-science-for-broader-therapeutic-reach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/soligenix-nasdaq-sngx-leverages-platform-science-for-broader-therapeutic-reach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JEPQ","PSQ","GPIQ","QQQY","QQQJ","QQQE","BK4139","TQQQ","MNQmain","USJW.SI","USAW.SI","SQQQ","NVIW.SI","SNGX","NQmain",".IXIC","QYLD","QLD","QID","TSYW.SI","QYLG","QQQM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614604911","title":"Soligenix Receives Positive Opinion From the European Medicines Agency on the Request for Orphan Drug Designation for Sgx945 for the Treatment of BehÇEt's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2614604911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614604911?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:33","pubTimestamp":1772109194,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZM19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":63,"code":"91000000","status":"200"}]}}